611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Cancer
Resources
Basic InformationLatest News
Could Common Vitamin Supplements Raise Lung Cancer Risk?Females Show Better Response to CRT in Esophageal CancerOutdoor Nighttime Light Exposure Linked to Breast Cancer RiskArsenic Levels Higher in Patients With Nonmelanoma Skin CancersRadioiodine Therapy for Thyroid Cancer Doesn't Up Stroke RiskOne-Quarter With Early Breast Cancer Strongly Considers CPMFDA Approves New Treatment for Acute Lymphoblastic LeukemiaNew Treatment Approved for Deadly Blood CancerHigh-Cal Foods May Raise Cancer Risk in Women, Even Without Weight GainAlternative Medicine Alone as Cancer Treatment Linked to Lowered SurvivalPerceived Social Support Lower for Cancer Caregivers Vs PatientsCan a Blood Test Detect a Range of Cancers Earlier?Heart Risks May Rise After Cancer DiagnosisCaregivers Have a Worse View of Cancer Patients' Functional StatusShort-Term Risk of Arterial Embolism Up in Cancer PatientsEndometrial Ablation Doesn't Increase Cancer RiskResearchers ID Genes in Mice That Cause Aggressive Brain CancerMultigene Panel Tests Can ID Hereditary Kidney CancerHospital Volume, Quality Impact Survival in Ovarian CancerPatient Profile Impacts QOL With Radiation Tx in Head, Neck CancerAntiperspirant Use Seems Safe During Breast Cancer Treatment: StudyOpioid Prescription Rates Higher in Cancer SurvivorsCancer Takes Financial Toll, Even With InsuranceFor Cancer Patients in the ER, Delirium Linked to Poor OutcomesBlood Test Can Screen for Rare Sinus Cancer, Study FindsColorectal Cancer Mortality Rates Down in Blacks, Up in WhitesDeaths From Colon Cancer Up Among Younger White AmericansOsteoporosis Meds Up BMD in Nonmetastatic Prostate CancerIntervention May Cut Muscle Loss From RT for Head & Neck CancerNot All 80-, 90-Year-Olds With Rectal Cancer Are TreatedChildhood Cancer Radiation May Cause Unwanted Gene Mutation in SomeNew Treatment Approved for Acute Myeloid LeukemiaYoung Cancer Survivors Struggle to Resume Social ActivitiesIdhifa Approved for Some With Acute Myeloid LeukemiaBreast-Feeding Lowers Mom's Breast Cancer Risk: StudyReview: Positive Link for Alcohol, Nonmelanoma Skin CancerChemo Plus Hyperthermia Active in Advanced Pancreatic CancerThyroid Cancer Tied to Regular Thyroxine Use in HypothyroidismInterval Training Cuts CVD Risk in Testicular Cancer SurvivorsTotal, Saturated Fat Linked to Increased Risk of Lung CancerTreatment Costs Can Be Another Blow to Cancer PatientsLack of Training Linked to Cancer Patient Caregiver BurdenMelanoma Isn't the Only Serious Skin CancerMany With Cancer Hospitalized, Undergo Imaging at End of Life$100 Sweetens the Pot for a ColonoscopyVascular Targeted Photodynamic Tx Aids Low-Risk Prostate CancerObesity in Teen Years Tied to Colon Cancer Risk in AdulthoodASCO Addresses Cancer Drug PricingSenator McCain Faces a Tough Cancer FoeMore Patients OK'd for Cancer Trials Under Obamacare: Study
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Blood Test May Spot Lung Cancer's Return, Even Before Scans

HealthDay News
by -- Robert Preidt
Updated: Mar 20th 2017

new article illustration

MONDAY, March 20, 2017 (HealthDay News) -- A blood test can detect the return of lung cancer months before CT and PET scans, a new study suggests.

The research included 48 adults with stage 2 or 3 locally advanced non-small cell lung cancer (NSCLC). The patients were aged 31 to 84. All were treated with chemotherapy and radiation.

Blood samples were taken before treatment, during treatment, and at six different times during the two years following treatment. The blood samples were checked for increased levels of circulating tumor cells, the researchers said.

The blood tests were able to detect lung cancer recurrence an average of six months before CT and PET scans, the investigators found.

The study was presented March 16 at a meeting of the American Society for Radiation Oncology, in San Francisco. Research presented at meetings should be viewed as preliminary until published in a peer-reviewed journal.

"The additional lead time afforded by an earlier diagnosis may enable doctors to better tailor alternative and salvage treatments to improve their patients' outcomes and quality of life," said lead author Chimbu Chinniah. He is a research fellow in radiation oncology at the University of Pennsylvania School of Medicine in Philadelphia.

"Earlier detection of recurrence may even translate into an increased likelihood of curing these patients when their tumor burden is lowest and thus more likely to respond to therapy," Chinniah suggested in a society news release.

According to the study's senior author, Dr. Charles Simone II, "The future use of circulating tumor cells as a diagnostic and prognostic tool for localized NSCLC looks promising."

Simone said that imaging tests -- such as CT and PET scans -- will remain "the cornerstone of post-treatment surveillance."

But blood tests could be used together with imaging scans. This combination might be a better way to monitor patients after treatment, he added. Simone is an associate professor of radiation oncology at the University of Maryland School of Medicine, in Baltimore.

More information

The U.S. National Cancer Institute has more on lung cancer.